Antimicrobial resistance—a threat to the world’s sustainable development

References

• Review on Antimicrobial Resistance. Tackling a crisis for the health and wealth of nations. London, United Kingdom: Review on Antimicrobial Resistance; 2014.
   Google Scholar
• Daulaire N, Bang A, Tomson G, Kalyango JN, Cars O. Universal access to effective antibiotics is essential for tackling antibiotic resistance. J Law Med Ethics. 2015;43(Suppl 3):17–21.
   PubMed Web of Science ®Google Scholar
• Mendelson M, Røttingen JA, Gopinathan U, Hamer DH, Wertheim H, Basnyat B, et al. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet. 2015;387:188–98.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO global strategy for containment of antimicrobial resistance. Geneva: World Health Organization; 2001. Available at: http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf?ua =1.
   Google Scholar
• World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015. Available at: http://www.who.int/drugresistance/global_action_plan/en/.
   Google Scholar
• General Assembly Resolution 70/1. Transforming our world: the 2030 Agenda for Sustainable Development - A/RES/70/1. New York, USA: United Nations; 2015.
   Google Scholar
• Nathan C, Cars O. Antibiotic resistance – problems, progress, and prospects. N Engl J Med. 2014;371:1761–3.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Health in 2015: from MDGs to SDGs. Geneva: World Health Organization; 2015. Available at: http://www.who.int/gho/publications/mdgs-sdgs/en/.
   Google Scholar
• ReAct - Action on Antibiotic Resistance. Toolbox - introduction. Uppsala, Sweden: ReAct; 2016. Available at: http://www.reactgroup.org/toolbox/.
   Google Scholar
• So AD, Shah TA, Roach S, Ling Chee Y, Nachman KE. An integrated systems approach is needed to ensure the sustainability of antibiotic effectiveness for both humans and animals. J Law Med Ethics. 2015:43(Suppl 3):38–45.
   PubMed Web of Science ®Google Scholar
• UN Commission on life-saving commodities for women and children. Commisioner's report. New York, USA: Every Women Every Child; 2012.
   Google Scholar
• Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168–175.
   PubMed Web of Science ®Google Scholar
• Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2014;385:430–40.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global health estimates: deaths, disability-adjusted life year (DALYs), years of life lost (YLL) and years lost due to disability (YLD) by cause, age and sex. Geneva: World Health Organization; 2015. Available at: http://www.who.int/healthinfo/global_burden_disease/en/.
   Google Scholar
• World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: World Health Organization; 2012. doi: 10.1016/S0968-8080(12)40660-7.
   Google Scholar
• Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401–22.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: the growing threat of multidrug-resistant gonorrhea. MMWR Morb Mortal Wkly Rep. 2013;62:103–6.
   PubMed Web of Science ®Google Scholar
• Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351:S5–S7.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014. Available at: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf.
   Google Scholar
• TenoRes study group. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016 Jan 28 [Epub ahead of print]. Available at: http://www.thelancet.com/article/S1473309915005368/fulltext.
   Google Scholar
• World Health Organization. World malaria report 2015. Geneva: World Health Organization; 2015. Available at: http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/.
   Google Scholar
• World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015. Available at: http://www.who.int/tb/publications/global_report/en/.
   Google Scholar
• World Health Organization. Achieving the malaria MDG target: reversing the incidence of malaria 2000–2015. Geneva: World Health Organization; 2015. Available at: http://www.who.int/malaria/publications/atoz/9789241509442/en/.
   Google Scholar
• Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis. 2015;15:1429–37.
   PubMed Web of Science ®Google Scholar
• Gudiol C, Carratalà J. Antibiotic resistance in cancer patients. Expert Rev Anti Infect Ther. 2014;12:1003–16.
   PubMed Web of Science ®Google Scholar
• Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:182–90.
   PubMed Web of Science ®Google Scholar
• Tomson G, Vlad I. The need to look at antibiotic resistance from a health systems perspective. Ups J Med Sci. 2014;119:117–24.
   PubMed Web of Science ®Google Scholar
• White House. National action plan for combating multi-resistance tuberculosis. Washington D.C.: White House; 2015.
   Google Scholar
• Smith RD, Yago M, Millar M, Coast J. Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. J Health Econ. 2005;24:1055–75.
   PubMed Web of Science ®Google Scholar
• Grace D. Review of evidence on antimicrobial resistance and animal agriculture in developing countries. London, United Kingdom: Evidence on Demand; 2015.
   Google Scholar
• Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015;112:5649–54.
   PubMed Web of Science ®Google Scholar
• Graham DW, Knapp CW, Christensen BT, McCluskey S, Dolfing J. Appearance of β-lactam resistance genes in agricultural soils and clinical isolates over the 20(th) century. Sci Rep. 2016;6:21550.
   PubMed Web of Science ®Google Scholar
• Food and Agriculture Organization of United Nations & World Health Organization. Codex texts on foodborne antimicrobial resistance. Rome, Italy: Food and Agriculture Organization of United Nations & World Health Organization; 2015.
   Google Scholar
• World Health Organization, Dept. of Communicable Disease Prevention, Control and Eradication; Danish Veterinary Institute; Danmarks jordbrugsforskning. Impacts of antimicrobial growth promoter termination in Denmark: the WHO international review panel’s evaluation of the termination of the use of antimicrobial growth promoters in Denmark: Foulum, Denmark 6–9 November 2002. Geneva: World Health Organization; 2003. Available at: http://www.who.int/iris/handle/10665/68357.
   Google Scholar
• Baquero F, Martínez J-L Cantón R. Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol. 2008;19:260–5.
   PubMed Web of Science ®Google Scholar
• Martínez JL. Antibiotics and antibiotic resistance genes in natural environments. Science. 2008;321:365–7.
   PubMed Web of Science ®Google Scholar
• Larsson DGJ, de Pedro C, Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater. 2007;148:751–55.
   PubMed Web of Science ®Google Scholar
• Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7:e1002158.
   PubMed Web of Science ®Google Scholar
• Heyman G, Cars O, Bejarano M-T, Peterson S. Access, excess, and ethics–towards a sustainable distribution model for antibiotics. Ups J Med Sci. 2014;119:134–41.
   PubMed Web of Science ®Google Scholar
• Hoffman SJ, Outterson K, Røttingen JA, Cars O, Clift C, Rizvi Z, et al. An international legal framework to address antimicrobial resistance. Bull World Health Organ. 2015;93:66.
   PubMed Web of Science ®Google Scholar
• Zorzet A. Overcoming scientific and structural bottlenecks in antibacterial discovery and development. Ups J Med Sci. 2014;119:170–5.
   PubMed Web of Science ®Google Scholar
• Silver LL. Challenges of antibacterial discovery. Clin Microbiol Rev. 2011;24:71–109.
   PubMed Web of Science ®Google Scholar
• Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2015;387:296–307.
   PubMed Web of Science ®Google Scholar
• Cars O. Securing access to effective antibiotics for current and future generations. Whose responsibility? Ups J Med Sci. 2014;119:209–14.
   PubMed Web of Science ®Google Scholar